Stig Lyngbæk

1.8k total citations
20 papers, 1.1k citations indexed

About

Stig Lyngbæk is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Cancer Research. According to data from OpenAlex, Stig Lyngbæk has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Stig Lyngbæk's work include Protease and Inhibitor Mechanisms (6 papers), Acute Myocardial Infarction Research (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Stig Lyngbæk is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Acute Myocardial Infarction Research (6 papers) and Adipokines, Inflammation, and Metabolic Diseases (5 papers). Stig Lyngbæk collaborates with scholars based in Denmark, Sweden and Switzerland. Stig Lyngbæk's co-authors include Jesper Eugen‐Olsen, Tine W. Hansen, Jørgen Jeppesen, Michael Hecht Olsen, Steen B. Haugaard, Allan Linneberg, Ove Andersen, Jacob Louis Marott, Thomas Sehestedt and Mogens Fenger and has published in prestigious journals such as JAMA, Journal of Bone and Joint Surgery and The American Journal of Cardiology.

In The Last Decade

Stig Lyngbæk

20 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stig Lyngbæk Denmark 14 374 278 232 190 149 20 1.1k
Moritz Wyler von Ballmoos United States 14 408 1.1× 91 0.3× 333 1.4× 163 0.9× 53 0.4× 29 1.3k
Tomasz Pielak Denmark 7 192 0.5× 149 0.5× 104 0.4× 111 0.6× 86 0.6× 14 554
Alain Stépanian France 22 301 0.8× 74 0.3× 164 0.7× 174 0.9× 573 3.8× 49 1.7k
Aurélie Mailhac Lebanon 18 410 1.1× 222 0.8× 662 2.9× 152 0.8× 168 1.1× 62 1.4k
Matthew Kutcher United States 26 146 0.4× 65 0.2× 569 2.5× 265 1.4× 162 1.1× 72 2.4k
Jacqueline Halton Canada 24 229 0.6× 86 0.3× 352 1.5× 109 0.6× 655 4.4× 56 2.1k
Stefan Greisenegger Austria 21 410 1.1× 58 0.2× 179 0.8× 640 3.4× 110 0.7× 43 1.5k
Rolf Dario Frank Germany 16 147 0.4× 30 0.1× 148 0.6× 118 0.6× 299 2.0× 29 936
Bartłomiej Perek Poland 18 470 1.3× 43 0.2× 502 2.2× 213 1.1× 38 0.3× 151 1.2k
Thomas Severin Switzerland 19 568 1.5× 27 0.1× 200 0.9× 161 0.8× 69 0.5× 43 1.2k

Countries citing papers authored by Stig Lyngbæk

Since Specialization
Citations

This map shows the geographic impact of Stig Lyngbæk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stig Lyngbæk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stig Lyngbæk more than expected).

Fields of papers citing papers by Stig Lyngbæk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stig Lyngbæk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stig Lyngbæk. The network helps show where Stig Lyngbæk may publish in the future.

Co-authorship network of co-authors of Stig Lyngbæk

This figure shows the co-authorship network connecting the top 25 collaborators of Stig Lyngbæk. A scholar is included among the top collaborators of Stig Lyngbæk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stig Lyngbæk. Stig Lyngbæk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lyngbæk, Stig, Christian Selmer, Ole Ahlehoff, et al.. (2020). SuPAR is associated with death and adverse cardiovascular outcomes in patients with suspected coronary artery disease. Scandinavian Cardiovascular Journal. 54(6). 339–345. 12 indexed citations
2.
Vishram, Julie K.K., Tine W. Hansen, Christian Torp‐Pedersen, et al.. (2016). Relationship Between Two Common Lipoprotein Lipase Variants and the Metabolic Syndrome and Its Individual Components. Metabolic Syndrome and Related Disorders. 14(9). 442–448. 3 indexed citations
3.
Rundgren, Malin, et al.. (2015). The Inflammatory Marker suPAR After Cardiac Arrest. Therapeutic Hypothermia and Temperature Management. 5(2). 89–94. 13 indexed citations
4.
Eckardt, Henrik, Stig Lyngbæk, Per Jensen, et al.. (2015). Symptomatic Venous Thromboembolism Following Fractures Distal to the Knee. Journal of Bone and Joint Surgery. 97(6). 470–477. 21 indexed citations
5.
Theilade, Simone, Stig Lyngbæk, Tine W. Hansen, et al.. (2014). Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes. Journal of Internal Medicine. 277(3). 362–371. 62 indexed citations
6.
Lyngbæk, Stig, Per Winkel, Jens Peter Gøtze, et al.. (2013). Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide. European Journal of Preventive Cardiology. 21(10). 1275–1284. 25 indexed citations
7.
Lyngbæk, Stig, Charlotte Andersson, Jacob Louis Marott, et al.. (2013). Soluble Urokinase Plasminogen Activator Receptor for Risk Prediction in Patients Admitted with Acute Chest Pain. Clinical Chemistry. 59(11). 1621–1629. 51 indexed citations
8.
Andersson, Charlotte, Stig Lyngbæk, Mia Nielsen, et al.. (2012). Association of Clopidogrel Treatment With Risk of Mortality and Cardiovascular Events Following Myocardial Infarction in Patients With and Without Diabetes. JAMA. 308(9). 882–882. 38 indexed citations
9.
Schmiegelow, Michelle, Christian Torp‐Pedersen, Gunnar Gislason, et al.. (2012). Relation of Body Mass Index to Risk of Stent Thrombosis After Percutaneous Coronary Intervention. The American Journal of Cardiology. 110(11). 1592–1597. 8 indexed citations
10.
Lyngbæk, Stig, Thomas Sehestedt, Jacob Louis Marott, et al.. (2012). CRP and suPAR are differently related to anthropometry and subclinical organ damage. International Journal of Cardiology. 167(3). 781–785. 95 indexed citations
11.
Lyngbæk, Stig, Jacob Louis Marott, Daniél V. Møller, et al.. (2012). Usefulness of Soluble Urokinase Plasminogen Activator Receptor to Predict Repeat Myocardial Infarction and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention. The American Journal of Cardiology. 110(12). 1756–1763. 75 indexed citations
12.
Lyngbæk, Stig, Jacob Louis Marott, Thomas Sehestedt, et al.. (2012). Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score. International Journal of Cardiology. 167(6). 2904–2911. 112 indexed citations
13.
Schneider, Mikael, Ditte Caroline Andersen, Asli Silahtaroglu, et al.. (2011). Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry. Journal of Molecular Histology. 42(4). 289–299. 31 indexed citations
14.
Sehestedt, Thomas, Stig Lyngbæk, Jesper Eugen‐Olsen, et al.. (2011). Soluble urokinase plasminogen activator receptor is associated with subclinical organ damage and cardiovascular events. Atherosclerosis. 216(1). 237–243. 76 indexed citations
15.
Eugen‐Olsen, Jesper, Ove Andersen, Allan Linneberg, et al.. (2010). Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population. Journal of Internal Medicine. 268(3). 296–308. 305 indexed citations
16.
Olsen, Michael Hecht, Thomas Sehestedt, Stig Lyngbæk, et al.. (2010). Urine Albumin/Creatinine Ratio, High Sensitivity C-Reactive Protein and N-Terminal Pro Brain Natriuretic Peptide - Three New Cardiovascular Risk Markers - Do They Improve Risk Prediction and Influence Treatment?. Current Vascular Pharmacology. 8(1). 134–139. 11 indexed citations
17.
Lyngbæk, Stig, R Ripa, Mandana Haack‐Sørensen, et al.. (2009). Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells. International journal of cardiac imaging. 26(3). 273–284. 19 indexed citations
18.
Lyngbæk, Stig, Mikael Schneider, Jane Lindschou Hansen, & Søren P. Sheikh. (2006). Cardiac regeneration by resident stem and progenitor cells in the adult heart. Basic Research in Cardiology. 102(2). 101–114. 73 indexed citations
19.
Lyngbæk, Stig, et al.. (2006). Recurrent acute pancreatitis due to eosinophilic gastroenteritis. Case report and literature review.. PubMed. 7(2). 211–7. 27 indexed citations
20.
Rognan, Didier, Anette Stryhn, Lars Fugger, et al.. (2000). Modeling the interactions of a peptide-major histocompatibility class I ligand with its receptors. I. Recognition by two αβ T cell receptors. Journal of Computer-Aided Molecular Design. 14(1). 53–69. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026